Syndax Pharmaceuticals (SNDX) Change in Account Payables (2016 - 2025)
Historic Change in Account Payables for Syndax Pharmaceuticals (SNDX) over the last 11 years, with Q3 2025 value amounting to -$3.5 million.
- Syndax Pharmaceuticals' Change in Account Payables rose 4712.14% to -$3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 87567.33%. This contributed to the annual value of $1.7 million for FY2024, which is 7032.61% down from last year.
- As of Q3 2025, Syndax Pharmaceuticals' Change in Account Payables stood at -$3.5 million, which was up 4712.14% from $7.3 million recorded in Q2 2025.
- In the past 5 years, Syndax Pharmaceuticals' Change in Account Payables registered a high of $7.3 million during Q2 2025, and its lowest value of -$6.7 million during Q3 2024.
- Over the past 5 years, Syndax Pharmaceuticals' median Change in Account Payables value was $676000.0 (recorded in 2022), while the average stood at $543052.6.
- Its Change in Account Payables has fluctuated over the past 5 years, first skyrocketed by 26676.83% in 2021, then plummeted by 82928.99% in 2023.
- Quarter analysis of 5 years shows Syndax Pharmaceuticals' Change in Account Payables stood at $547000.0 in 2021, then tumbled by 605.3% to -$2.8 million in 2022, then surged by 241.53% to $3.9 million in 2023, then soared by 71.98% to $6.7 million in 2024, then plummeted by 152.42% to -$3.5 million in 2025.
- Its last three reported values are -$3.5 million in Q3 2025, $7.3 million for Q2 2025, and -$1.6 million during Q1 2025.